Get the Stockscreener App
62.28
0.56%
-0.3522
After Hours:
62.28
0.0005
+0.00%
Invesco Biotechnology Genome Etf stock is traded at $62.28, with a volume of 7,116.
It is down -0.56% in the last 24 hours and up +5.47% over the past month.
See More
Previous Close:
$62.63
Open:
$62.19
24h Volume:
7,116
Relative Volume:
0.88
Market Cap:
$281.93M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.19%
1M Performance:
+5.47%
6M Performance:
-10.35%
1Y Performance:
-2.78%
1-Day Range:
$61.65
$62.42
1-Week Range:
$61.01
$62.84
52-Week Range:
$54.52
$72.84
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Name
Invesco Biotechnology Genome Etf
Sector
Industry
Phone
-
Address
-
Compare PBE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
62.28 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
277.22 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
563.51 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
566.17 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
220.85 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
485.93 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Stock (PBE) Latest News
Envestnet Asset Management Inc. Sells 1,256 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Russell Investments Group Ltd. Grows Holdings in Capricor Therapeutics Inc (NASDAQ:CAPR) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Russell Investments Group Ltd. - Defense World
Bank of Montreal Can Cuts Stock Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco S&P SmallCap Information Technology ETF (NASDAQ:PSCT) Shares Sold by Wells Fargo & Company MN - Defense World
Wells Fargo & Company MN Decreases Stake in Invesco Trust for Investment Grade Municipals (NYSE:VGM) - Defense World
Wells Fargo & Company MN Decreases Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
When (PBE) Moves Investors should Listen - news.stocktradersdaily.com
LPL Financial LLC Increases Position in ProShares Nasdaq-100 High Income ETF (NASDAQ:IQQQ) - Defense World
LPL Financial LLC Boosts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Raymond James Financial Inc. Purchases Shares of 18,878 Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Raymond James Financial Inc. Takes Position in PIMCO Municipal Income Fund III (NYSE:PMX) - Defense World
Commonwealth Equity Services LLC Has $1.73 Million Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
Biotech stocks and ETFs at a potential turning point - Fidelity
23andMe (NASDAQ: ME): Bankruptcy Filing and Strategic Sale Process - Value The Markets
(PBE) Trading Advice - Stock Traders Daily
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Jones Financial Companies Lllp Increases Stock Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
2Seventy Bio (TSVT): Surge Following Acquisition Announcement - Value The Markets
(PBE) Trading Signals - Stock Traders Daily
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value The Markets
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
How the (PBE) price action is used to our Advantage - news.stocktradersdaily.com
Moderna Faces Challenges, MRNA Stock Continues YTD Decline - Value the Markets
(PBE) Long Term Investment Analysis - Stock Traders Daily
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Top Canadian Genetics Stocks of 2025 - The Motley Fool Canada
Trading (PBE) With Integrated Risk Controls - Stock Traders Daily
(PBE) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Atara extends losses after FDA clinical hold - MSN
Is Invesco Building & Construction ETF (PKB) a Good Investment Right Now - espeaks.co.uk
Is the Invesco S&P 500 Equal Weight Technology ETF (RSPT) Worth Your Investment? - espeaks.co.uk
Broader population could benefit from Novartis spinal muscular atrophy treatment - MSN
Enhanced rat genome map identifies over 1,100 new protein-coding genes - MSN
(PBE) Investment Analysis and Advice - Stock Traders Daily
Jane Street Group LLC Makes New $295,000 Investment in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Sonic Healthcare (OTCMKTS:SKHHY) Stock Price Passes Above Fifty Day Moving Average – Should You Sell? - Defense World
Jane Street Group LLC Invests $295,000 in Morgan Stanley Direct Lending (NYSE:MSDL) - Defense World
Jane Street Group LLC Reduces Holdings in Fidelity Sustainable High Yield ETF (NYSEARCA:FSYD) - Defense World
Jane Street Group LLC Grows Position in Getty Images Holdings, Inc. (NYSE:GETY) - Defense World
Agenus Inc. (NASDAQ:AGEN) Stock Holdings Lessened by Jane Street Group LLC - Defense World
Jane Street Group LLC Has $258,000 Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World
AllianceBernstein (NYSE:AB) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
KeyCorp Forecasts Strong Price Appreciation for DoorDash (NASDAQ:DASH) Stock - Defense World
University City-Based Verismo Therapeutics Acquired by HLB Group of South Korea - MSN
6 Best Health Care ETFs to Buy for 2025 | Investing | U.S. News - Money/ US News
(PBE) Technical Pivots with Risk Controls - Stock Traders Daily
MML Investors Services LLC Sells 351 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
4,475 Shares in Direxion Daily Junior Gold Miners Index Bull 2X Shares (NYSEARCA:JNUG) Bought by HighTower Advisors LLC - Defense World
Fmr LLC Buys 519 Shares of Amplify AI Powered Equity ETF (NYSEARCA:AIEQ) - Defense World
Invesco Biotechnology Genome Etf Stock (PBE) Financials Data
There is no financial data for Invesco Biotechnology Genome Etf (PBE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.51%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):